Results for tag: "Congenital Heart Defect"

Congenital heart defects (CHD) are structural abnormalities of the heart that are present at birth. They are the most common type of birth defect, affecting approximately 1 in 100 newborns. CHD can range from mild to severe, and can involve the heart's walls, valves, or blood vessels. Treatment for CHD can include medications, surgery, or a combination of both. The Congenital Heart Defect market within the context of Cardiology is a rapidly growing field. Advances in medical technology have enabled earlier diagnosis and improved treatment options for CHD. This has led to increased demand for medical devices and services related to CHD. Additionally, the increasing prevalence of CHD has driven the need for better patient care and improved outcomes. Companies in the Congenital Heart Defect market include Boston Scientific, Medtronic, Abbott, Edwards Lifesciences, and St. Jude Medical. These companies provide a range of products and services related to CHD, including medical devices, diagnostics, and treatments. Show Less Read more